(Q46223982)

20 December 2017

title

Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome (English)

1 reference

20 December 2017

Valérie Devauchelle-Pensec

author

7

Valérie Devauchelle-Pensec

1 reference

20 December 2017

Jacques-Eric Gottenberg

3

Jacques-Eric Gottenberg

0 references

Raphaèle Seror

6

Raphaèle Seror

1 reference

20 December 2017

Pierre Youinou

12

Pierre Youinou

1 reference

20 December 2017

13

Jacques-Olivier Pers

1 reference

20 December 2017

2

Alain Saraux

1 reference

20 December 2017

10

Xavier Mariette

1 reference

20 December 2017

Gabriel J Tobón

1

Gabriel J Tobón

1 reference

20 December 2017

Stéphanie Rist

9

Stéphanie Rist

1 reference

20 December 2017

author name string

Luca Quartuccio

4

1 reference

20 December 2017

Martina Fabris

5

1 reference

20 December 2017

Jacques Morel

8

1 reference

20 December 2017

Salvatore De Vita

11

1 reference

20 December 2017

publication date

1 December 2013

1 reference

20 December 2017

published in

Arthritis & Rheumatology

1 reference

20 December 2017

volume

65

1 reference

20 December 2017

issue

12

1 reference

20 December 2017

page(s)

3218-3227

1 reference

20 December 2017

Sjögren's syndrome: autoimmune epithelitis

cites work

1 reference

Disturbance of cytokine networks in Sjögren's syndrome

21 January 2018

1 reference

Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias

21 January 2018

1 reference

Is the blood B-cell subset profile diagnostic for Sjogren syndrome?

21 January 2018

1 reference

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

21 January 2018

1 reference

Increased Risk of Lymphoma in Sicca Syndrome

21 January 2018

1 reference

Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome

21 January 2018

1 reference

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

21 January 2018

1 reference

Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects

21 January 2018

1 reference

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

21 January 2018

1 reference

Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

21 January 2018

1 reference

Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects

21 January 2018

1 reference

Flt3 ligand (FL) and its influence on immune reactivity

21 January 2018

1 reference

The role of FLT3 in haematopoietic malignancies

21 January 2018

1 reference

The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

21 January 2018

1 reference

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort

21 January 2018

1 reference

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

21 January 2018

1 reference

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents

21 January 2018

1 reference

BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.

21 January 2018

1 reference

Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach

21 January 2018

1 reference

Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors

21 January 2018

1 reference

Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome

21 January 2018

1 reference

Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.38129

1 reference

20 December 2017

1 reference

20 December 2017